WHO Approves Bavarian Nordic’s Mpox Vaccine for Adolescents
The World Health Organization (WHO) has approved Bavarian Nordic’s mpox vaccine, Jynneos, for adolescents aged 12 to 17. This age group is considered especially vulnerable […]
The World Health Organization (WHO) has approved Bavarian Nordic’s mpox vaccine, Jynneos, for adolescents aged 12 to 17. This age group is considered especially vulnerable […]
Introduction: The Africa Centres for Disease Control and Prevention (Africa CDC) has issued an urgent appeal for increased support from Western nations in combating the […]
In a landmark medical breakthrough, Russia has announced the development of a cancer vaccine that will be distributed free of cost. This initiative marks a […]
In an exciting development for the pharmaceutical and biotech sectors, two of the world’s leading pharmaceutical companies have announced a groundbreaking partnership to ramp up […]
A revolutionary indigenous gene therapy for Hemophilia A, a rare blood disorder, has recently delivered significant positive results in its first human trials. This breakthrough […]
The United Kingdom and Switzerland have unveiled a major investment in life sciences research, committing a combined £16 million to foster innovation in healthcare and […]
A novel immunotherapy for breast cancer is showing significant early results in clinical trials, offering new hope for patients with advanced forms of the disease. […]
A groundbreaking new coating process is addressing one of the most persistent challenges in the pharmaceutical industry: preserving the stability and efficacy of antibiotics. Specifically, […]